Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00268892

Extrait

The purpose of this extension study was to collect long-term safety and tolerability information to support a marketing authorisation application for a three-month dosage regimen of degarelix.


Critère d'inclusion

  • Prostate cancer


Liens